This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, S. Y. Articles by Klein-Szanto, A. J. P. Search for Related Content PubMed PubMed Citation Articles by Zhang, S. Y. Articles by Klein-Szanto, A. J. P.

E2F-1 Gene Transfer Enhances Invasiveness of Human Head and Neck Carcinoma Cell Lines¹

Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania [S. Y. Z., S. C. L., A. J. P. K-S.], and Department of Carcinogenesis, M. D. Anderson Cancer Center, Science Park, Smithville, Texas [D. G. J.]

The transcription factor E2F-1, a downstream regulator of the p16-cyclinD-Rb pathway, is required for cell cycle progression. Evidence shows that overexpression of E2F-1 can either promote or inhibit development of tumors, depending on tissue or experimental conditions. To study whether the E2F-1 gene plays a role in tumor progression, the expression of E2F-1 protein was evaluated in 10 human head and neck squamous cell carcinoma cell lines using Western blot analysis. In addition, the invasive ability of these cell lines was determined by evaluating the penetration of cell lines into the tracheal wall in an in vivo invasion assay using deepithelialized tracheas transplanted into the s.c. tissue of Scid mice. This study showed that the aggressive cell lines had higher expression of E2F-1 than the less invasive cell lines. To evaluate the hypothesis that E2F-1 enhances invasiveness, we selected two cell lines, SCC9 and SCC12, for a gene transfer experiment. These cell lines exhibited low invasive ability with low expression of E2F-1. Two stable clones with overexpression of transfected E2F-1 gene and two clones with their respective vector-alone control were selected from each cell line for in vivo invasion evaluation. The clones containing the transfected E2F-1 gene had significantly higher invasive ability than their respective vector-alone clones. Flow cytometry showed that parental, transfected E2F-1, and vector-alone cells had a similar proliferation pattern under normal culture conditions. Nevertheless, transfected E2F-1 cells exhibited a higher portion of cells in S phase than the control cells after serum-starvation and refeeding. The results indicated that overexpression of E2F-1 plays a positive role in cell cycle reentry from quiescence and is associated with increased in vivo invasiveness.

This article has been cited by other articles:

				C.-l. Huang, D. Liu, J. Nakano, H. Yokomise, M. Ueno, K. Kadota, and H. Wada E2F1 Overexpression Correlates with Thymidylate Synthase and Survivin Gene Expressions and Tumor Proliferation in Non Small-Cell Lung Cancer Clin. Cancer Res., December 1, 2007; 13(23): 6938 - 6946. [Abstract] [Full Text] [PDF]

				J. N. Davis, K. J. Wojno, S. Daignault, M. D. Hofer, R. Kuefer, M. A. Rubin, and M. L. Day Elevated E2F1 Inhibits Transcription of the Androgen Receptor in Metastatic Hormone-Resistant Prostate Cancer Cancer Res., December 15, 2006; 66(24): 11897 - 11906. [Abstract] [Full Text] [PDF]

				J. N. Davis, M. T. McCabe, S. W. Hayward, J. M. Park, and M. L. Day Disruption of Rb/E2F Pathway Results in Increased Cyclooxygenase-2 Expression and Activity in Prostate Epithelial Cells Cancer Res., May 1, 2005; 65(9): 3633 - 3642. [Abstract] [Full Text] [PDF]

				J. Yang, M. Chatterjee-Kishore, S. M. Staugaitis, H. Nguyen, K. Schlessinger, D. E. Levy, and G. R. Stark Novel Roles of Unphosphorylated STAT3 in Oncogenesis and Transcriptional Regulation Cancer Res., February 1, 2005; 65(3): 939 - 947. [Abstract] [Full Text] [PDF]

				T. V. Sharp, F. Munoz, D. Bourboulia, N. Presneau, E. Darai, H.-W. Wang, M. Cannon, D. N. Butcher, A. G. Nicholson, G. Klein, et al. LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription PNAS, November 23, 2004; 101(47): 16531 - 16536. [Abstract] [Full Text] [PDF]

				R. A. Kwong, T. V. Nguyen, R. J. Bova, J. G. Kench, I. E. Cole, E. A. Musgrove, S. M. Henshall, and R. L. Sutherland Overexpression of E2F-1 Is Associated with Increased Disease-free Survival in Squamous Cell Carcinoma of the Anterior Tongue Clin. Cancer Res., September 1, 2003; 9(10): 3705 - 3711. [Abstract] [Full Text] [PDF]

				J. Stanelle, T. Stiewe, C. C. Theseling, M. Peter, and B. M. Putzer Gene expression changes in response to E2F1 activation Nucleic Acids Res., April 15, 2002; 30(8): 1859 - 1867. [Abstract] [Full Text] [PDF]

				D. E. Bassi, R. Lopez De Cicco, H. Mahloogi, S. Zucker, G. Thomas, and A. J. P. Klein-Szanto Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells PNAS, August 28, 2001; 98(18): 10326 - 10331. [Abstract] [Full Text] [PDF]